Non-binding offers for Galapagos’s cell therapies assets came mostly from financial investors, and none offered sufficient terms or financing to support the business, the company said. Galapagos’s exit from cell therapy work will lead to site closures in Europe, China, and the U.S.
The post Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty appeared first on MedCity News.
From Firewalls to Zero Trust: 10 Best Practices for Next-Gen Business Data Security
In today’s ever-evolving digital landscape, businesses must establish robust data security strategies to safeguard sensitive information from modern threats. The reality of escalating cyberattacks, such
